Tsinglaw features a professional legal team dedicated to the biopharmaceutical sector. Our members practice law in both China and the US, bringing a diverse range of expertise. Beyond their deep legal knowledge, our team members also have backgrounds with organizations such as the China National Intellectual Property Administration (CNIPA), the World Intellectual Property Organization (WIPO), various arbitration institutions, and experience from both multinational pharmaceutical corporations and domestic pharmaceutical enterprises.

Tsinglaw has a wealth of experience providing comprehensive litigation and non-litigation services, supporting well-known multinational corporations, state-owned enterprises, listed companies, and start-ups in the biopharmaceutical sector, covering the entire lifecycle of R&D, production, sales and beyond. Our expertise includes international and domestic dispute resolution (litigation and arbitration), intellectual property compliance and risk control, licensing transactions (in-licensing and out-licensing), and international trade.